1.69
Schlusskurs vom Vortag:
$1.72
Offen:
$1.7
24-Stunden-Volumen:
67,745
Relative Volume:
0.26
Marktkapitalisierung:
$72.60M
Einnahmen:
$51.13M
Nettoeinkommen (Verlust:
$-93.80M
KGV:
-0.7578
EPS:
-2.23
Netto-Cashflow:
$-129.10M
1W Leistung:
+1.81%
1M Leistung:
+11.18%
6M Leistung:
+44.44%
1J Leistung:
-38.99%
Repare Therapeutics Inc Stock (RPTX) Company Profile
Firmenname
Repare Therapeutics Inc
Sektor
Branche
Telefon
(857) 412-7018
Adresse
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Vergleichen Sie RPTX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RPTX
Repare Therapeutics Inc
|
1.69 | 73.03M | 51.13M | -93.80M | -129.10M | -2.23 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-06-09 | Hochstufung | Stifel | Hold → Buy |
2023-02-03 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2023-01-06 | Eingeleitet | CapitalOne | Overweight |
2022-04-12 | Herabstufung | Stifel | Buy → Hold |
2022-03-17 | Fortgesetzt | Goldman | Buy |
2021-09-23 | Eingeleitet | Stifel | Buy |
2021-09-13 | Eingeleitet | H.C. Wainwright | Buy |
2021-06-28 | Eingeleitet | Guggenheim | Buy |
2021-03-01 | Eingeleitet | Berenberg | Buy |
2020-10-28 | Eingeleitet | Northland Capital | Outperform |
2020-07-14 | Eingeleitet | Cowen | Outperform |
2020-07-14 | Eingeleitet | Goldman | Neutral |
2020-07-14 | Eingeleitet | Morgan Stanley | Overweight |
2020-07-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Repare Therapeutics Inc Aktie (RPTX) Neueste Nachrichten
Is Repare Therapeutics Inc. benefiting from innovation trendsJuly 2025 Volume & Weekly High Return Stock Forecasts - khodrobank.com
Market reaction to Repare Therapeutics Inc.’s recent newsJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser
What’s the recovery path for long term holders of Repare Therapeutics Inc.2025 Top Decliners & Safe Capital Growth Trade Ideas - Newser
What momentum shifts mean for Repare Therapeutics Inc.Trend Reversal & AI Enhanced Execution Alerts - Newser
What does recent volatility data suggest for Repare Therapeutics Inc.July 2025 Update & Expert Curated Trade Ideas - Newser
Can volume confirm reversal in Repare Therapeutics Inc.Trade Risk Summary & Real-Time Chart Pattern Alerts - Newser
Key resistance and support levels for Repare Therapeutics Inc.July 2025 EndofMonth & Real-Time Volume Triggers - Newser
Evaluating Repare Therapeutics Inc. with trendline analysis2025 Key Highlights & Weekly High Return Opportunities - Newser
What data driven models say about Repare Therapeutics Inc.’s futureEarnings Recap Report & AI Driven Stock Price Forecasts - Newser
Will Repare Therapeutics Inc. benefit from green energy policiesMarket Activity Report & High Accuracy Investment Entry Signals - khodrobank.com
How to read the order book for Repare Therapeutics Inc.Portfolio Performance Summary & Community Trade Idea Sharing - Newser
Ranking Repare Therapeutics Inc. among high performing stocks via toolsOil Prices & Fast Exit/Entry Strategy Plans - Newser
Is it time to cut losses on Repare Therapeutics Inc.Insider Buying & Breakout Confirmation Trade Signals - Newser
Chart based analysis of Repare Therapeutics Inc. trendsChart Signals & Real-Time Chart Pattern Alerts - Newser
Leading vs lagging indicators on Repare Therapeutics Inc. performanceEarnings Risk Summary & Real-Time Volume Spike Alerts - Newser
Is Repare Therapeutics Inc. stock a good dividend stock2025 Price Targets & Daily Entry Point Alerts - khodrobank.com
Repare Therapeutics Inc. stock prediction for this weekTrade Analysis Summary & Weekly Market Pulse Updates - Newser
Using R and stats models for Repare Therapeutics Inc. forecasting2025 Market Trends & Weekly Consistent Profit Watchlists - Newser
Should you wait for a breakout in Repare Therapeutics Inc.Market Risk Report & Reliable Trade Execution Plans - Newser
Is Repare Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Analyst Calls & Verified Stock Trade Ideas - Newser
Is Repare Therapeutics Inc. a potential multi bagger2025 Performance Recap & Low Drawdown Momentum Trade Ideas - khodrobank.com
What’s Repare Therapeutics Inc.’s historical returnJuly 2025 Market Mood & Risk Managed Investment Signals - khodrobank.com
How to recover losses in Repare Therapeutics Inc. stockEarnings Beat & Accurate Entry and Exit Point Alerts - Newser
Repare Therapeutics Inc. Reaches Critical Trendline Support getLinesFromResByArray error: size == 0 - kangso.co.kr
Live market analysis of Repare Therapeutics Inc.Portfolio Return Report & Consistent Income Trade Ideas - Newser
Repare Therapeutics Reports Q2 2025 Results and Strategic Moves - MSN
How to track smart money flows in Repare Therapeutics Inc.2025 Earnings Impact & Consistent Return Investment Signals - Newser
Regression Model Predicts Rangebound Movement in Repare Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Predicting Repare Therapeutics Inc. trend using moving averages2025 Performance Recap & Weekly High Momentum Picks - Newser
Can Repare Therapeutics Inc. hit a new high this monthRate Cut & Long-Term Capital Growth Strategies - Newser
Quantitative breakdown of Repare Therapeutics Inc. recent move2025 Analyst Calls & Long-Term Safe Investment Plans - Newser
Using RSI to spot recovery in Repare Therapeutics Inc.July 2025 Analyst Calls & Daily Stock Trend Watchlist - Newser
What MACD and RSI say about Repare Therapeutics Inc.2025 Analyst Calls & Risk Managed Investment Signals - Newser
Finanzdaten der Repare Therapeutics Inc-Aktie (RPTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Repare Therapeutics Inc-Aktie (RPTX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER |
Mar 12 '25 |
Sale |
1.14 |
5,611 |
6,397 |
80,297 |
Forte Steve | EVP, CHIEF FINANCIAL OFFICER |
Mar 12 '25 |
Sale |
1.14 |
6,884 |
7,848 |
54,786 |
Segal Lloyd Mitchell | PRESIDENT AND CEO |
Mar 12 '25 |
Sale |
1.14 |
21,179 |
24,144 |
124,394 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):